United States News All stories

AEVEX (NYSE:AVEX) was selected for a contract valued at up to $92.2 million over three years to support the Department of War’s Test Resource Management Center SkyRange program.

LuxExperience (NYSE:LUXE) reported fourth-quarter fiscal 2026 net sales of €653.6 million, up 6.1% year-over-year on a reported basis and 7.6% excluding foreign exchange effects.

Starbucks (NASDAQ:SBUX) is considering selling a majority stake in its Japan business in a potential transaction that could value the operation at approximately $3 billion, according to people familiar with the matter.

SK Hynix (NASDAQ:SKHY) is in discussions with Intel (NASDAQ:INTC) about potential arrangements to manufacture memory chips in the United States, according to people familiar with the talks.

McCormick & Company (NYSE:MKC) faces a review by Britain’s competition regulator over its planned acquisition of the majority of Unilever’s foods business.

Oil prices declined on Wednesday after a two-day rally, with Brent crude futures falling $1.22 to $107.53 per barrel and U.S. West Texas Intermediate futures dropping $1.64 to $104.19 per barrel following an unexpected increase in U.S. crude inventories.

Brookfield (NYSE:BAM) agreed through its flagship private equity strategy to acquire 100% of Reliance Worldwide Corporation for US$3.38 per share in an all-cash transaction with an enterprise value of approximately US$2.8 billion.

Ispire Technology I (NASDAQ:ISPR) reported an adjusted quarterly loss of $0.24 per share for the quarter ended June 2026, compared with the Zacks Consensus Estimate of a $0.02 loss per share.

Intuitive Machines (NASDAQ:LUNR) completed in-orbit commissioning and transferred the SXM-11 satellite to SiriusXM after the geostationary communications satellite became fully operational.

Shengfeng Development (NASDAQ:SFWL) reported unaudited first-half 2026 revenue of approximately $311.8 million, up 18.4% year-over-year, with net income increasing to about $6.6 million.

HeartSciences (NASDAQ:HSCS) reported fiscal first-quarter 2027 results with no meaningful revenue, a net loss of $3.2 million, and progress updates on its proposed business combination with Fortitude Mining Holdings.

Vera Therapeutics (NASDAQ:VERA) reported final Phase 3 ORIGIN 3 results showing TRUTAKNA (atacicept-vymj) stabilized kidney function and reduced disease progression over two years in adults with primary IgA nephropathy at risk of progression.

Lithium Argentina (NYSE:LAR) completed a $180 million strategic investment from Ganfeng through a six-year unsecured convertible note to refinance debt and extend its maturity profile.

The Buckle (NYSE:BKE) authorized a quarterly dividend of $0.35 per share following its Board of Directors meeting held on September 14, 2026.

Connect Biopharma (NASDAQ:CNTB) reported preliminary topline Phase 2 results from the Seabreeze STAT Asthma study showing rademikibart improved lung function as an add-on treatment for acute asthma exacerbations with type 2 inflammation.

Rocket Pharmaceuticals (NASDAQ:RCKT) received alignment from the U.S. Food and Drug Administration on continued enrollment, dosing, and key design elements for its global Phase 2 pivotal trial of RP-A501 in patients with Danon disease.

Pulse Biosciences (NASDAQ:PLSE) completed enrollment in the PRECISE-BTN clinical study evaluating its nPulse Vybrance Percutaneous Electrode System for treating symptomatic benign thyroid nodules.

SU Group Holdings (NASDAQ:SUGP) agreed through its wholly owned subsidiary to acquire 100% of KM Safety Solution Company for HK$5.616 million, or approximately US$721,000.

Vera Bradley (NASDAQ:VRA) reported fiscal second-quarter 2027 consolidated net revenue of $71.6 million, up 1.1% year-over-year, and returned to profitability from continuing operations.

BioVie (NASDAQ:BIVI) reported topline Phase 2 ADDRESS-LC trial results for bezisterim in Long COVID, showing statistically significant improvements in pre-specified subgroups with higher baseline fatigue, cognitive impairment, and post-exertional malaise.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported interim topline data from a Phase 1/2a clinical trial of ARO-DIMER-PA, an investigational RNA interference therapy designed to silence PCSK9 and APOC3 genes for patients with mixed hyperlipidemia.

V2X (NYSE:VVX) received a $46 million delivery order under the Enterprise-Wide Agile Acquisition Contract IDIQ to provide carriage equipment production for the U.S. Air Force’s Long Range Standoff cruise missile program.

RTX (NYSE:RTX) announced that its Pratt & Whitney business completed the F135 Engine Core Upgrade Risk Reduction Design Review, advancing the propulsion modernization program for the F-35 aircraft.

51Talk Online Education Group (NYSE:COE) reported second-quarter 2026 net revenue of $32.4 million, up 58.8% year-over-year, while active students with attended lesson consumption increased to about 138,100.